Pharmacy Consulting

Pharmacy Healthcare Solutions Inc. (PHSI) consults with pharmaceutical manufacturers, PBMs, retail pharmacy chains, and software companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSI with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.

News & Events

ComputerTalk for the Pharmacist May/June 2015

PHSI Consultants Alan Sekula and Ann Johnson contributed to the May/June 2015 edition of ComputerTalk for the Pharmacist. In their Viewpoints article, Alan and Ann review the impact that biosimiliars will have on various stakeholders: drug compendia, payers, wholesalers, pharmacies, and manufacturers.

PHSI to Attend NACDS Total Store Expo

PHSI President Tim Kosty, Vice President Don Dietz, and many of PHSI’s consultants will be attending the 2015 NACDS Total Store Expo in Denver, Colorado on August 22-25. PHSI will have an exhibit set up at booth number 2016. If you would like to schedule a meeting with a PHSI team member, please click here to send us Read More →

ComputerTalk for the Pharmacist March/April 2015

PHSI Consultant Dave Schuetz contributed to the March/April 2015 edition of ComputerTalk for the Pharmacist. In his Viewpoints article, Dave discusses the challenges surrounding e-prescribing of controlled substances and responsibilities that pharmacies have when utilizing the process and pharmacy system.  Click here to read Dave’s article entitled “E-Prescriptions Leading to Uncharted Waters”.

Latest from the Blog

Changes to Naloxone Policy

On May 20, 2015, Dr. Karen Thacker of the Allegheny County Health Department issued a press release announcing a standing order to allow pharmacists in Allegheny County (Pennsylvania) to dispense intranasal and injectable naloxone without a prescription to at-risk patients and caregivers. This standing order is allowed by Pennsylvania Act 139, which was passed in Read More →

Biosimilars & Originators – What’s the Link?

CMS issued a new guidance on biosimilar reimbursement. It sounds simple but now the drug compendia must link the biosimilar with the originator or someone else will meet this marketplace need.

DEA Ends National Prescription Drug Take-Back Days

The Drug Enforcement Agency (DEA) began sponsoring the National Prescription Drug Take-Back Day in September 2010, with bi-annual Take-Back Days in April and September, running through September 2014. Over a five year period, the DEA sponsored nine total Drug Take-Back Days and collected over 4 million pounds of prescriptions drugs. The DEA originally created the Read More →